Table 4.
Univariate analysis | Multivariate analysisa) | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Male | 2.6 | 1.2–5.7 | 0.01 | 1.8 | 0.8–4.0 | 0.14 |
EF ≤ 35% | 4.8 | 2.2–104 | < 0.01 | 3.6 | 1.6–8.1 | < 0.01 |
Emotionalerstress | 0.4 | 0.1–1.1 | 0.10 | |||
Inotropic drugs | 3.9 | 1.9–7.9 | < 0.01 | 2.2 | 1.0–4.8 | 0.04 |
Diabetes mellitus Typ II | 1.0 | 0.7–1.4 | 0.81 | |||
Hypertension | 0.9 | 0.7–1.2 | 0.64 | |||
Apical ballooning | 1.1 | 0.8–1.4 | 0.39 | |||
History of cancer | 1.7 | 0.7–4.2 | 0.21 | |||
Smoking | 0.7 | 0.3–1.6 | 0.49 |
HR hazard ratio, EF ejection fraction, CRP c-reactive protein, GFR glomerular filtration rate
aOnly the following variables with significant effects in univariate analysis were analyzed by multivariate Cox regression: Male, EF ≤ 35%, Inotropic drugs
The bolded indication highlight significant values